About BioBeats
BioBeats is a Technology company based in London (United Kingdom) founded in 2012, and was acquired by Huma in April 2020. Provider of data aggregation platform from various wearable devices. It operates in the Technology and Healthcare sectors. BioBeats has raised $6.23 million across 4 funding rounds from investors including Huma, AXA Venture Partners and Oxford Science Enterprises. Its focus areas include HealthTech, Employee Health IT, Tech Enabled Services and Mental Health. Its legal entity is BIOBEATS GROUP LTD.
Company details
Founded in 2012 in London, United Kingdom, BioBeats operates in the health technology sector. A platform is provided to aggregate data from various wearable devices, where machine learning is applied to analyze vitals such as activity, breathing, and sleep. Real-time insights on health and stress are delivered through an app and dashboard. Personalized insights and health coaching services are also offered to users.
Apps and channels of BioBeats
its YouTube channel BioBeats has 169 subscribers and 21 videos.
Videos from BioBeats
The most watched videos on BioBeats's YouTube channel, BioBeats (169 subscribers). Click a video to play it here.
More on BioBeats.
Funding Insights of BioBeats
BioBeats has successfully raised a total of $6.23M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.23M
- Total Rounds 4
- Last Round Series A — $3M
- First Round $650,000
(Aug 2013)
- Investors Count 8
All 4 funding rounds of BioBeats with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $3M | Series A | – | Oxford Science Enterprises, White Cloud | – |
| Apr 2016 | $2.28M | Series A | – | White Cloud Capital | |
| Jul 2014 | $299,000 | Seed | – | – | – |
| Aug 2013 | $650,000 | Seed | – | – |
9 investors in total: 9 institutional.
Investors in BioBeats
BioBeats has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Huma, AXA Venture Partners and Oxford Science Enterprises.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment management services for science ventures are provided in Oxford. | oxfordscienceenterprises.com | Oxford, United Kingdom | ||
Deep tech venture capital firm investing in European and global startups. | iqcapital.vc | |||
Strategic venture capital investments are made in growing companies. | 2014 | whcloud.com | London, United Kingdom | |
Seed and early-stage investments are focused on French tech firms. | 2013 | axavp.com | Paris, France | |
Tech & Offline focused Seed stage VC Firm investing primarily in Asia and the US | zhenfund.com | Beijing, China | ||
US focused seed and early-stage VC firm | eniac.vc | San Francisco, United States | ||
| cantora.com | ||||
White Cloud is recognized for producing high-quality household paper products. | mywhitecloud.com | USA | ||
Digital and AI-first health products are developed by Huma. | 2011 | huma.com | London, United Kingdom |
Investor details for BioBeats
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioBeats
1 people are tracked at BioBeats (1 in leadership).
| Name | Role | Group |
|---|---|---|
Fantàsha Kassam | Founder | Leadership |
Complete people profiles for BioBeats
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioBeats
4 dated milestones of BioBeats across 8 years, from founding to its latest funding, stage changes and deals.
- Founded BioBeats is founded.
- Funding First funding round of $650K.
- Funding Latest funding round, Series A, of $3.0M.
- Exit Acquired by Huma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biobeats
Complete news archive for BioBeats
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioBeats
BioBeats was founded in 2012 and raised its 1st funding round 1 year after it was founded.
BioBeats is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
BioBeats is a funded company, having raised a total of $6.23M across 4 funding rounds to date. The company's 1st funding round was a Seed of $650K, raised on Aug 2013.
Founded in 2012 in London, United Kingdom, BioBeats operates in the health technology sector. A platform is provided to aggregate data from various wearable devices, where machine learning is applied to analyze vitals such as activity, breathing, and sleep. Real-time insights on health and stress are delivered through an app and dashboard. Personalized insights and health coaching services are also offered to users.
BioBeats has 9 investors. Key investors include Huma, AXA Venture Partners, Oxford Science Enterprises, White Cloud, and IQ Capital.
BioBeats operates through Biobeats Group Ltd.
Yes. BioBeats was acquired by Huma in April 2020.